Phase 2 (Actuate-1801 Part 3B) trial meets primary endpoint and demonstrates a clinically meaningful increase in median overall survival (10.1…
The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive, HER2-negative advanced…
Phase III NAPOLI 3 trial is the largest and has the longest follow-up for an interventional study in metastatic pancreatic…
Extended Phase 1b trial follow-up on IMA203 PRAME cell therapy in 33 heavily pretreated patients with metastatic melanoma demonstrates favorable…
MILLIONS OF FANS FROM ACROSS THE WORLD TUNED IN TO WATCH THE ICONIC ROCK BAND'S UNMISSABLE PERFORMANCE AHEAD OF THE…
HONG KONG, May 31, 2025 /PRNewswire/ -- In May last year, the International Association of Anti-Corruption Authorities (IAACA), a 180-member-strong…
Mongolia faces a crunch parliamentary vote on Monday which could lead to fall of coalition governmentNew analysis from Mongolian Economic…
DELHI, India, May 31, 2025 /PRNewswire/ -- oneworld® alliance today continues to enhance its global capabilities and build a powerful…
NEW DELHI, May 30, 2025 /PRNewswire/ -- Rays Power Infra Limited, a prominent business of developing and implementing solar solutions…
More than half of residents with tardive dyskinesia (TD) residing in long-term care (LTC) settings do not receive standard of…